We are live on ! Find out more
IMUX icon

Immunic

21 hedge funds and large institutions have $13M invested in Immunic in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

5% more funds holding

Funds holding: 2021 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.11% less ownership

Funds ownership: 2.11%2.01% (-0.11%)

37% less capital invested

Capital invested by funds: $20.7M → $13M (-$7.7M)

Holders
21
Holders Change
+1
Holders Change %
+5%
% of All Funds
0.46%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
5
Reduced
2
Closed
2
Calls
$333K
Puts
Net Calls
+$333K
Net Calls Change
-$2.34M

IMUX Hedge Fund Activity: Q1 2020 in Review

21 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q1 2020, worth a combined $13M — down 37% from $20.7M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new IMUX positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $58.7K. The largest seller was BlackRock, cutting an estimated $12.7K.

  • 21 institutional investors held Immunic (IMUX) as of Q1 2020, up from 20 in Q4 2019.
  • Funds reported $13M of Immunic stock for Q1 2020, down 37% quarter-over-quarter.
  • 3 funds opened new Immunic positions in Q1 2020 and 2 closed out, a net change of +1 holder.
  • The largest Immunic buyer in Q1 2020 was Renaissance Technologies, an estimated $58.7K added.
  • The largest Immunic seller in Q1 2020 was BlackRock, an estimated $12.7K sold.

Based on aggregated 13F filings for Q1 2020.